Ibuprofen DC 85 W

Ibuprofen DC 85 W, in granule and solid form, is designed for oral drug delivery solutions. With multiple labeling claims, including dioxin-free, gluten-free, sustainable, and more, it functions as an anti-inflammatory agent. Health benefits cover analgesics, anti-inflammatory drugs, antipyretics, and pain reduction. The product targets the healthcare and pharma markets, utilizing direct compression, dry granulation, and wet granulation manufacturing technologies.

Chemical Name: Ibuprofen

CAS Number: 15687-27-1

Dosage Form: Capsules, Tablets

Ingredient Origin: Non-Animal Origin, Synthetic

Labeling Claims: Additive-free, Aflatoxin-free, Allergen-free, BSE-free, Dioxin-free, Gluten-free, Latex-free, Melamine-free, Nitrosamines-free, Non-GMO, Phthalates-free, Sustainable, TSE-free

Synonyms: (+-)-Ibuprofen, (±)-2-(p-isobutylphenyl)propionic acid, (±)-ibuprofen, (±)-p-isobutylhydratropic acid, (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid, (4-isobutylphenyl)-α-methylacetic acid, (RS)-ibuprofen, 2-(4-isobutylphenyl)propanoic acid, 4-Isobutylhydratropic acid, alpha-(4-Isobutylphenyl)Propionic Acid, alpha-(P-Isobutylphenyl)Propionic Acid, p-Isobutyl-2-phenylpropionic acid, p-Isobutylhydratropic acid, α-(4-isobutylphenyl)propionic acid, α-(p-isobutylphenyl)propionic acid

  • TypeDocument Name
View All Documents

Enhanced TDS

Identification & Functionality

Features & Benefits

Benefit Claims (Health)
Labeling Claims
Key Benefits
  • Ibuprofen DC 85 W is able to be compressed into tablets with minimum amount of lubricant
  • Excellent tablet engraving
  • Maximizes production speed while minimizing stickiness
  • Allows for smaller tablet sizes compared to those with pure Ibuprofen which are easier to swallow

Applications & Uses

Markets
Applications
Dosage Form
Manufacturing Technology
Recommended Applications
  • Due to its analgesic, antipyretic and anti-inflammatory actions, it is used in the treatment of inflammatory conditions such as rheumatoid arthritis, osteoarthritis, mild to moderate pain, dysmenorrhea, headache, and fever.
  • The common active ingredient dosage in tablets is 200, 400, 600 and 800 mg. The OTC dosage forms are mainly the 200 and 400 mg forms (except for the United States and some other countries, where the 200 mg form is the only OTC form). Other common dosage forms are capsules, syrups, suspensions, suppositories, and topical dosage forms like creams and gels.
Processing of Ibuprofen
  • Oral film-coated tablets showing rapid disintegration and fast release of the active substance. The common strengths are 200, 400, 600 and 800 mg. There are also slow release formulations containing 800 mg of Ibuprofen.
  • Oral suspensions which are used mainly for patients who have difficulties swallowing tablets and for pediatric patients.
  • Creams and gels for topical application, generally used for treating rheumatic disorders or sports injuries.
Recommendation for Direct Compression
  • Today the manufacturing of ibuprofen tablets is often done by direct compression. Using this method, the expensive and time-consuming wet granulation method can be avoided. But in general, ibuprofen has the disadvantage of sticking on the tablet tools so that the process must be interrupted often.
  • Therefore, direct compression formulations with a high content of ibuprofen per tablet are often avoided. Mostly tablets with an ibuprofen content of maximum 60% are compressed.
  • BASF offers a formulated ibuprofen product ideal for direct compression: Ibuprofen DC 85 W. The direct compression (DC) grade ensures that tablet sticking is minimized and allows for excellent tablet engraving.
  • Furthermore, Ibuprofen DC 85 W has a lower angle of repose compared to standard grades, resulting in improved flowability.

Properties

Physical Form
Appearance
White granules, free-flowing, homogeneous material
Typical Properties
ValueUnitsTest Method / Conditions
Angle of Repose33degree-
Tapped Densityapprox. 0.64g/ml-
Bulk Densityapprox. 0.55g/ml-
Composition
ValueUnitsTest Method / Conditions
Croscarmellose Sodium, Microcrystalline Cellulose, Colloidal Silicon Dioxide15%-
Ibuprofen85%-
Sieve Test
ValueUnitsTest Method / Conditions
Particle Size (Retained on 0.3mm Sieve)min. 45%-
Particle Size (Retained on 0.85mm Sieve)min. 15%-

Regulatory & Compliance

Technical Details & Test Data

SEM Photograph

BTC Europe GmbH Ibuprofen DC 85 W - Sem Photograph

Formulation Guidance

BTC Europe GmbH Ibuprofen DC 85 W - Formulation Guidance

  • Direct compression is possible
  • Dry granulation (roller compaction) is possible
  • Wet granulation (fluid-bed or high-shear granulation) is possible

Packaging & Availability

Country Availability
Packaging Type
Packaging Information
  • 50KG Fiber drums

Storage & Handling

Storage Information & Retest Period
  • Store tightly closed. Carefully reseal the container after opening
  • Retest Period : 36 months